Discussion Historically, survival rates for advanced NSCLC were disappointingly low, and treatment-related toxicities were extremely significant.
← all excerpts
Positive Correlation of Peripheral CD8<sup>+</sup> T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
1
—
—